Israel Launches Flu Vaccination Campaign Amid Gradual Supply

Israel's health maintenance organizations (HMOs) have commenced their annual influenza vaccination campaign for the 2026-2027 winter season, with a phased rollout of vaccines. Clalit, the largest HMO, has ordered over a million injectable flu vaccines and 25,000 nasal spray vaccines for children aged two to 49. Initially, vaccinations will be available at central clinics and designated sites, expanding to all Clalit clinics as more supply arrives throughout September and October.

Maccabi Healthcare Services began its campaign immediately, reporting a 28% increase in vaccinations last year compared to the previous one, reaching approximately 560,000 members. This marks the highest vaccination rate since the 2020-2021 COVID-19 outbreak. Maccabi is urging the public, especially those 65 and older, pregnant women, children, and chronically ill individuals, to get vaccinated early.

Meuhedet received its first shipment of flu vaccines, which are expected to be administered starting next week. The HMO has procured around 250,000 doses, including high-dose vaccines for individuals 65 and older and those at risk, as well as injectable and nasal spray options. Meuhedet anticipates significant vaccine availability by October and advises booking appointments in advance due to the gradual supply.

Health officials are emphasizing the importance of early vaccination for all, particularly high-risk populations, to prevent severe illness and complications. Last winter saw significant flu-related morbidity and hospitalizations. Experts warn that flu can lead to pneumonia, hospitalization, heart attacks, strokes, and even death, especially in young children and the elderly. Data from the Southern Hemisphere suggests a potentially higher incidence of flu among children this season, though it is not a definitive predictor for Israel. Despite potential virus mutations, the vaccine is expected to provide significant protection, particularly for vulnerable groups.